These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 23198737

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. VALUE in hypertension treatment.
    Berk BC, Bisognano JD.
    Curr Hypertens Rep; 2004 Dec; 6(6):411-3. PubMed ID: 15527682
    [No Abstract] [Full Text] [Related]

  • 5. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.
    Christogiannis LG, Kostapanos MS, Tellis CC, Milionis HJ, Tselepis AD, Elisaf MS.
    J Hum Hypertens; 2013 Jan; 27(1):44-50. PubMed ID: 22129607
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amlodipine seems to be superior to valsartan in decreasing microalbuminuria in newly diagnosed hypertensive patients: a novel effect to be explained with hyperfiltration?
    Ay SA, Cakar M, Karaman M, Balta S, Demirkol S, Unlu M, Kurt O, Altun B, Akhan M, Arslan E, Koc B, Bulucu F.
    Ren Fail; 2013 Jan; 35(3):357-60. PubMed ID: 23297711
    [Abstract] [Full Text] [Related]

  • 8. Valsartan Amlodipine Randomized Trial (VART): design, methods, and preliminary results.
    Nakayama K, Kuwabara Y, Daimon M, Shindo S, Fujita M, Narumi H, Mizuma H, Komuro I.
    Hypertens Res; 2008 Jan; 31(1):21-8. PubMed ID: 18360014
    [Abstract] [Full Text] [Related]

  • 9. The comparative effects of valsartan and amlodipine on vascular microinflammation in newly diagnosed hypertensive patients.
    Unlu M, Karaman M, Ay SA, Balta S, Cakar M, Demirkol S, Celik T, Arslan E, Demirbas S, Turker T, Yaman H, Bulucu F, Sağlam K.
    Clin Exp Hypertens; 2013 Jan; 35(6):418-23. PubMed ID: 23148500
    [Abstract] [Full Text] [Related]

  • 10. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
    Mann J, Julius S.
    Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
    [Abstract] [Full Text] [Related]

  • 11. Single-pill combination of amlodipine and valsartan in the management of hypertension.
    Flack JM, Hilkert R.
    Expert Opin Pharmacother; 2009 Aug; 10(12):1979-94. PubMed ID: 19606937
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term potential of angiotensin receptor blockade for cardiovascular protection in hypertension: the VALUE trial. Valsartan Antihypertensive Long-term Use Evaluation.
    Julius S.
    Cardiology; 1999 Aug; 91 Suppl 1():8-13. PubMed ID: 10449889
    [Abstract] [Full Text] [Related]

  • 14. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.
    Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F.
    Clin Pharmacol Ther; 1996 Sep; 60(3):341-6. PubMed ID: 8841157
    [Abstract] [Full Text] [Related]

  • 15. Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
    Epstein M, Hollenberg NK.
    Am J Hypertens; 2004 Jul; 17(7):638-9; author reply 639-40. PubMed ID: 15233985
    [No Abstract] [Full Text] [Related]

  • 16. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
    Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group.
    Lancet; 2004 Jun 19; 363(9426):2022-31. PubMed ID: 15207952
    [Abstract] [Full Text] [Related]

  • 17. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI, Sonmez A, Caglar K, Celik T, Yenicesu M, Eyileten T, Acikel C, Oguz Y, Yavuz I, Vural A.
    Nephrology (Carlton); 2007 Apr 19; 12(2):147-53. PubMed ID: 17371337
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May 19; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
    Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O.
    J Hypertens; 2006 Nov 19; 24(11):2163-8. PubMed ID: 17053536
    [Abstract] [Full Text] [Related]

  • 20. Two amlodipine/ARB combinations for hypertension.
    Med Lett Drugs Ther; 2007 Dec 17; 49(1276):101-2. PubMed ID: 18084152
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.